nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—NTRK1—asthma	0.336	1	CbGaD
Crizotinib—CYP3A5—Beclomethasone—asthma	0.0157	0.0764	CbGbCtD
Crizotinib—CYP3A5—Salmeterol—asthma	0.0157	0.0764	CbGbCtD
Crizotinib—ABCB1—Fluticasone furoate—asthma	0.0135	0.0656	CbGbCtD
Crizotinib—CYP3A5—Fluticasone Propionate—asthma	0.0134	0.0649	CbGbCtD
Crizotinib—ABCB1—Indacaterol—asthma	0.011	0.0535	CbGbCtD
Crizotinib—CYP3A4—Fluticasone furoate—asthma	0.0081	0.0393	CbGbCtD
Crizotinib—CYP3A4—Budesonide—asthma	0.00722	0.035	CbGbCtD
Crizotinib—CYP3A4—Indacaterol—asthma	0.0066	0.032	CbGbCtD
Crizotinib—CYP3A4—Ciclesonide—asthma	0.0066	0.032	CbGbCtD
Crizotinib—CYP3A4—Flunisolide—asthma	0.00614	0.0298	CbGbCtD
Crizotinib—CYP3A4—Salbutamol—asthma	0.00614	0.0298	CbGbCtD
Crizotinib—CYP3A4—Salmeterol—asthma	0.00614	0.0298	CbGbCtD
Crizotinib—ABCB1—Loratadine—asthma	0.00588	0.0285	CbGbCtD
Crizotinib—CYP3A4—Ipratropium bromide—asthma	0.00547	0.0265	CbGbCtD
Crizotinib—CYP3A4—Zileuton—asthma	0.00547	0.0265	CbGbCtD
Crizotinib—ABCB1—Methylprednisolone—asthma	0.00538	0.0261	CbGbCtD
Crizotinib—CYP3A4—Fluticasone Propionate—asthma	0.00522	0.0253	CbGbCtD
Crizotinib—CYP3A5—Hydrocortisone—asthma	0.00503	0.0244	CbGbCtD
Crizotinib—CYP3A4—Zafirlukast—asthma	0.00481	0.0234	CbGbCtD
Crizotinib—CYP3A4—Tiotropium—asthma	0.00414	0.0201	CbGbCtD
Crizotinib—CYP3A4—Aminophylline—asthma	0.00395	0.0192	CbGbCtD
Crizotinib—CYP3A4—Theophylline—asthma	0.00372	0.018	CbGbCtD
Crizotinib—CYP3A4—Montelukast—asthma	0.00352	0.0171	CbGbCtD
Crizotinib—CYP3A4—Loratadine—asthma	0.00352	0.0171	CbGbCtD
Crizotinib—ABCB1—Betamethasone—asthma	0.0035	0.017	CbGbCtD
Crizotinib—ABCB1—Prednisolone—asthma	0.00345	0.0168	CbGbCtD
Crizotinib—ABCB1—Hydrocortisone—asthma	0.00327	0.0159	CbGbCtD
Crizotinib—ABCB1—Prednisone—asthma	0.00326	0.0158	CbGbCtD
Crizotinib—CYP3A4—Methylprednisolone—asthma	0.00322	0.0156	CbGbCtD
Crizotinib—CYP3A5—Dexamethasone—asthma	0.00313	0.0152	CbGbCtD
Crizotinib—CYP3A4—Triamcinolone—asthma	0.00244	0.0119	CbGbCtD
Crizotinib—CYP3A4—Betamethasone—asthma	0.0021	0.0102	CbGbCtD
Crizotinib—CYP3A4—Prednisolone—asthma	0.00207	0.01	CbGbCtD
Crizotinib—ABCB1—Dexamethasone—asthma	0.00203	0.00988	CbGbCtD
Crizotinib—CYP3A4—Hydrocortisone—asthma	0.00196	0.00951	CbGbCtD
Crizotinib—CYP3A4—Prednisone—asthma	0.00195	0.00948	CbGbCtD
Crizotinib—CYP3A4—Dexamethasone—asthma	0.00122	0.00592	CbGbCtD
Crizotinib—PTK2—Pentoxifylline—Dyphylline—asthma	0.000961	0.246	CbGdCrCtD
Crizotinib—IGF1R—cardiovascular system—asthma	0.000481	0.00403	CbGeAlD
Crizotinib—DSTYK—lung—asthma	0.000479	0.00401	CbGeAlD
Crizotinib—TNK1—trachea—asthma	0.000478	0.004	CbGeAlD
Crizotinib—CDK7—adrenal gland—asthma	0.000468	0.00392	CbGeAlD
Crizotinib—LTK—lung—asthma	0.000468	0.00392	CbGeAlD
Crizotinib—CASK—lung—asthma	0.000468	0.00392	CbGeAlD
Crizotinib—TIE1—cardiovascular system—asthma	0.000468	0.00392	CbGeAlD
Crizotinib—MAP3K12—adrenal cortex—asthma	0.000467	0.00391	CbGeAlD
Crizotinib—ACVR1—adrenal cortex—asthma	0.000467	0.00391	CbGeAlD
Crizotinib—PTK2—respiratory system—asthma	0.000466	0.0039	CbGeAlD
Crizotinib—TBK1—respiratory system—asthma	0.000466	0.0039	CbGeAlD
Crizotinib—TAOK2—adrenal gland—asthma	0.000465	0.00389	CbGeAlD
Crizotinib—TYK2—respiratory system—asthma	0.000463	0.00388	CbGeAlD
Crizotinib—LIMK2—bronchus—asthma	0.000462	0.00387	CbGeAlD
Crizotinib—MAP3K12—bronchus—asthma	0.000458	0.00383	CbGeAlD
Crizotinib—ACVR1—bronchus—asthma	0.000458	0.00383	CbGeAlD
Crizotinib—MAPK7—lung—asthma	0.000453	0.0038	CbGeAlD
Crizotinib—TXK—lung—asthma	0.000453	0.0038	CbGeAlD
Crizotinib—FES—lung—asthma	0.000449	0.00376	CbGeAlD
Crizotinib—RPS6KB1—respiratory system—asthma	0.000449	0.00376	CbGeAlD
Crizotinib—EPHA3—adrenal gland—asthma	0.000448	0.00375	CbGeAlD
Crizotinib—ACVR1B—adrenal gland—asthma	0.000448	0.00375	CbGeAlD
Crizotinib—FGR—respiratory system—asthma	0.000446	0.00373	CbGeAlD
Crizotinib—AXL—respiratory system—asthma	0.000444	0.00372	CbGeAlD
Crizotinib—TESK1—trachea—asthma	0.000436	0.00365	CbGeAlD
Crizotinib—BMP2K—bronchus—asthma	0.000431	0.00361	CbGeAlD
Crizotinib—JAK3—adrenal gland—asthma	0.000427	0.00358	CbGeAlD
Crizotinib—ACVR1—cardiovascular system—asthma	0.000426	0.00357	CbGeAlD
Crizotinib—FLT3—cardiovascular system—asthma	0.000426	0.00357	CbGeAlD
Crizotinib—MET—lung—asthma	0.000424	0.00355	CbGeAlD
Crizotinib—EPHB4—respiratory system—asthma	0.000424	0.00355	CbGeAlD
Crizotinib—DCLK1—adrenal gland—asthma	0.000424	0.00355	CbGeAlD
Crizotinib—PLK4—adrenal gland—asthma	0.000422	0.00353	CbGeAlD
Crizotinib—JAK2—respiratory system—asthma	0.000421	0.00353	CbGeAlD
Crizotinib—RIPK2—epithelium—asthma	0.00042	0.00351	CbGeAlD
Crizotinib—STK4—adrenal gland—asthma	0.000419	0.00351	CbGeAlD
Crizotinib—EPHA2—respiratory system—asthma	0.000416	0.00349	CbGeAlD
Crizotinib—LIMK2—trachea—asthma	0.000415	0.00348	CbGeAlD
Crizotinib—NUAK2—trachea—asthma	0.000414	0.00346	CbGeAlD
Crizotinib—RIPK2—bronchus—asthma	0.000413	0.00346	CbGeAlD
Crizotinib—ACVR1—trachea—asthma	0.000411	0.00344	CbGeAlD
Crizotinib—CDK7—lung—asthma	0.00041	0.00344	CbGeAlD
Crizotinib—PTK2B—smooth muscle tissue—asthma	0.000408	0.00341	CbGeAlD
Crizotinib—TAOK2—lung—asthma	0.000407	0.00341	CbGeAlD
Crizotinib—TEK—respiratory system—asthma	0.000406	0.0034	CbGeAlD
Crizotinib—EPHA4—bronchus—asthma	0.0004	0.00335	CbGeAlD
Crizotinib—FER—adrenal gland—asthma	0.000396	0.00332	CbGeAlD
Crizotinib—ACVR1B—lung—asthma	0.000392	0.00328	CbGeAlD
Crizotinib—EPHA3—lung—asthma	0.000392	0.00328	CbGeAlD
Crizotinib—TNK1—adrenal gland—asthma	0.000392	0.00328	CbGeAlD
Crizotinib—TBK1—adrenal cortex—asthma	0.000391	0.00328	CbGeAlD
Crizotinib—PTK2—epithelium—asthma	0.00039	0.00326	CbGeAlD
Crizotinib—TYK2—adrenal cortex—asthma	0.000389	0.00325	CbGeAlD
Crizotinib—MAP4K1—adrenal gland—asthma	0.000388	0.00325	CbGeAlD
Crizotinib—BMPR1B—adrenal gland—asthma	0.000388	0.00325	CbGeAlD
Crizotinib—PTK2B—cardiovascular system—asthma	0.000388	0.00325	CbGeAlD
Crizotinib—RIPK2—cardiovascular system—asthma	0.000385	0.00322	CbGeAlD
Crizotinib—TBK1—bronchus—asthma	0.000384	0.00321	CbGeAlD
Crizotinib—PTK2—bronchus—asthma	0.000384	0.00321	CbGeAlD
Crizotinib—TYK2—bronchus—asthma	0.000381	0.00319	CbGeAlD
Crizotinib—TNK2—adrenal gland—asthma	0.000381	0.00319	CbGeAlD
Crizotinib—IGF1R—adrenal gland—asthma	0.000381	0.00319	CbGeAlD
Crizotinib—RPS6KB1—adrenal cortex—asthma	0.000376	0.00315	CbGeAlD
Crizotinib—IRAK1—bronchus—asthma	0.000376	0.00315	CbGeAlD
Crizotinib—PTK2—smooth muscle tissue—asthma	0.000375	0.00314	CbGeAlD
Crizotinib—MAP4K2—adrenal gland—asthma	0.000375	0.00314	CbGeAlD
Crizotinib—YES1—respiratory system—asthma	0.000375	0.00314	CbGeAlD
Crizotinib—RPS6KB1—epithelium—asthma	0.000375	0.00314	CbGeAlD
Crizotinib—JAK3—lung—asthma	0.000374	0.00313	CbGeAlD
Crizotinib—TYK2—smooth muscle tissue—asthma	0.000373	0.00312	CbGeAlD
Crizotinib—AXL—adrenal cortex—asthma	0.000373	0.00312	CbGeAlD
Crizotinib—DCLK1—lung—asthma	0.000372	0.00311	CbGeAlD
Crizotinib—STK10—respiratory system—asthma	0.000372	0.00311	CbGeAlD
Crizotinib—RIPK2—trachea—asthma	0.000371	0.00311	CbGeAlD
Crizotinib—TAOK3—respiratory system—asthma	0.00037	0.0031	CbGeAlD
Crizotinib—STK3—adrenal gland—asthma	0.00037	0.0031	CbGeAlD
Crizotinib—TIE1—adrenal gland—asthma	0.00037	0.0031	CbGeAlD
Crizotinib—PLK4—lung—asthma	0.00037	0.00309	CbGeAlD
Crizotinib—RPS6KB1—bronchus—asthma	0.000369	0.00309	CbGeAlD
Crizotinib—IRAK1—smooth muscle tissue—asthma	0.000368	0.00308	CbGeAlD
Crizotinib—STK4—lung—asthma	0.000367	0.00308	CbGeAlD
Crizotinib—LCK—bronchus—asthma	0.000367	0.00307	CbGeAlD
Crizotinib—RPS6KB1—smooth muscle tissue—asthma	0.000361	0.00302	CbGeAlD
Crizotinib—SRC—respiratory system—asthma	0.000361	0.00302	CbGeAlD
Crizotinib—AURKA—adrenal gland—asthma	0.000361	0.00302	CbGeAlD
Crizotinib—EPHA4—trachea—asthma	0.000359	0.003	CbGeAlD
Crizotinib—SLK—adrenal cortex—asthma	0.000359	0.003	CbGeAlD
Crizotinib—TESK1—adrenal gland—asthma	0.000358	0.003	CbGeAlD
Crizotinib—AXL—smooth muscle tissue—asthma	0.000358	0.00299	CbGeAlD
Crizotinib—TBK1—cardiovascular system—asthma	0.000357	0.00299	CbGeAlD
Crizotinib—PTK2—cardiovascular system—asthma	0.000357	0.00299	CbGeAlD
Crizotinib—EPHB4—adrenal cortex—asthma	0.000356	0.00298	CbGeAlD
Crizotinib—TYK2—cardiovascular system—asthma	0.000355	0.00297	CbGeAlD
Crizotinib—EPHB4—epithelium—asthma	0.000355	0.00297	CbGeAlD
Crizotinib—JAK2—epithelium—asthma	0.000352	0.00295	CbGeAlD
Crizotinib—SLK—bronchus—asthma	0.000352	0.00295	CbGeAlD
Crizotinib—EPHA2—adrenal cortex—asthma	0.000349	0.00293	CbGeAlD
Crizotinib—EPHB4—bronchus—asthma	0.000349	0.00292	CbGeAlD
Crizotinib—MERTK—adrenal gland—asthma	0.000348	0.00291	CbGeAlD
Crizotinib—EPHA2—epithelium—asthma	0.000348	0.00291	CbGeAlD
Crizotinib—FER—lung—asthma	0.000347	0.00291	CbGeAlD
Crizotinib—ALK—lung—asthma	0.000347	0.00291	CbGeAlD
Crizotinib—JAK2—bronchus—asthma	0.000347	0.0029	CbGeAlD
Crizotinib—TBK1—trachea—asthma	0.000345	0.00288	CbGeAlD
Crizotinib—PTK2—trachea—asthma	0.000345	0.00288	CbGeAlD
Crizotinib—TNK1—lung—asthma	0.000344	0.00288	CbGeAlD
Crizotinib—RPS6KB1—cardiovascular system—asthma	0.000344	0.00288	CbGeAlD
Crizotinib—EPHA2—bronchus—asthma	0.000343	0.00287	CbGeAlD
Crizotinib—TYK2—trachea—asthma	0.000342	0.00287	CbGeAlD
Crizotinib—EPHB4—smooth muscle tissue—asthma	0.000342	0.00286	CbGeAlD
Crizotinib—FGR—cardiovascular system—asthma	0.000341	0.00286	CbGeAlD
Crizotinib—MAP3K3—adrenal cortex—asthma	0.000341	0.00285	CbGeAlD
Crizotinib—TEK—adrenal cortex—asthma	0.000341	0.00285	CbGeAlD
Crizotinib—LIMK2—adrenal gland—asthma	0.00034	0.00285	CbGeAlD
Crizotinib—MAP4K1—lung—asthma	0.00034	0.00285	CbGeAlD
Crizotinib—BMPR1B—lung—asthma	0.00034	0.00285	CbGeAlD
Crizotinib—MAP3K19—lung—asthma	0.00034	0.00285	CbGeAlD
Crizotinib—AXL—cardiovascular system—asthma	0.00034	0.00285	CbGeAlD
Crizotinib—TEK—epithelium—asthma	0.000339	0.00284	CbGeAlD
Crizotinib—JAK2—smooth muscle tissue—asthma	0.000339	0.00284	CbGeAlD
Crizotinib—NUAK2—adrenal gland—asthma	0.000339	0.00284	CbGeAlD
Crizotinib—FLT3—adrenal gland—asthma	0.000337	0.00282	CbGeAlD
Crizotinib—MAP3K12—adrenal gland—asthma	0.000337	0.00282	CbGeAlD
Crizotinib—ACVR1—adrenal gland—asthma	0.000337	0.00282	CbGeAlD
Crizotinib—TEK—bronchus—asthma	0.000334	0.0028	CbGeAlD
Crizotinib—MAP3K3—bronchus—asthma	0.000334	0.0028	CbGeAlD
Crizotinib—MAP4K5—bronchus—asthma	0.000334	0.0028	CbGeAlD
Crizotinib—IGF1R—lung—asthma	0.000334	0.00279	CbGeAlD
Crizotinib—TNK2—lung—asthma	0.000334	0.00279	CbGeAlD
Crizotinib—RPS6KB1—trachea—asthma	0.000331	0.00278	CbGeAlD
Crizotinib—STK35—adrenal gland—asthma	0.00033	0.00276	CbGeAlD
Crizotinib—LCK—trachea—asthma	0.000329	0.00276	CbGeAlD
Crizotinib—MAP4K2—lung—asthma	0.000329	0.00275	CbGeAlD
Crizotinib—AXL—trachea—asthma	0.000328	0.00275	CbGeAlD
Crizotinib—TEK—smooth muscle tissue—asthma	0.000327	0.00274	CbGeAlD
Crizotinib—MAP4K5—smooth muscle tissue—asthma	0.000327	0.00274	CbGeAlD
Crizotinib—EPHB4—cardiovascular system—asthma	0.000325	0.00272	CbGeAlD
Crizotinib—STK3—lung—asthma	0.000324	0.00272	CbGeAlD
Crizotinib—TIE1—lung—asthma	0.000324	0.00272	CbGeAlD
Crizotinib—CSF1R—respiratory system—asthma	0.000324	0.00271	CbGeAlD
Crizotinib—JAK2—cardiovascular system—asthma	0.000323	0.0027	CbGeAlD
Crizotinib—ABL2—adrenal gland—asthma	0.000322	0.00269	CbGeAlD
Crizotinib—EPHB6—bronchus—asthma	0.000319	0.00267	CbGeAlD
Crizotinib—EPHA2—cardiovascular system—asthma	0.000319	0.00267	CbGeAlD
Crizotinib—BMP2K—adrenal gland—asthma	0.000318	0.00266	CbGeAlD
Crizotinib—AURKA—lung—asthma	0.000316	0.00265	CbGeAlD
Crizotinib—SLK—trachea—asthma	0.000316	0.00264	CbGeAlD
Crizotinib—YES1—adrenal cortex—asthma	0.000315	0.00264	CbGeAlD
Crizotinib—TESK1—lung—asthma	0.000314	0.00263	CbGeAlD
Crizotinib—EPHB4—trachea—asthma	0.000314	0.00263	CbGeAlD
Crizotinib—JAK2—trachea—asthma	0.000311	0.00261	CbGeAlD
Crizotinib—MAP3K3—cardiovascular system—asthma	0.000311	0.0026	CbGeAlD
Crizotinib—TEK—cardiovascular system—asthma	0.000311	0.0026	CbGeAlD
Crizotinib—TAOK3—adrenal cortex—asthma	0.000311	0.0026	CbGeAlD
Crizotinib—YES1—bronchus—asthma	0.000309	0.00258	CbGeAlD
Crizotinib—EPHA2—trachea—asthma	0.000308	0.00258	CbGeAlD
Crizotinib—PTK2B—adrenal gland—asthma	0.000307	0.00257	CbGeAlD
Crizotinib—STK10—bronchus—asthma	0.000306	0.00256	CbGeAlD
Crizotinib—MERTK—lung—asthma	0.000305	0.00255	CbGeAlD
Crizotinib—TAOK3—bronchus—asthma	0.000305	0.00255	CbGeAlD
Crizotinib—RIPK2—adrenal gland—asthma	0.000304	0.00255	CbGeAlD
Crizotinib—YES1—smooth muscle tissue—asthma	0.000302	0.00253	CbGeAlD
Crizotinib—SRC—epithelium—asthma	0.000302	0.00252	CbGeAlD
Crizotinib—MAP3K3—trachea—asthma	0.0003	0.00251	CbGeAlD
Crizotinib—MAP4K5—trachea—asthma	0.0003	0.00251	CbGeAlD
Crizotinib—LIMK2—lung—asthma	0.000298	0.0025	CbGeAlD
Crizotinib—NUAK2—lung—asthma	0.000297	0.00249	CbGeAlD
Crizotinib—MAP3K12—lung—asthma	0.000295	0.00247	CbGeAlD
Crizotinib—FLT3—lung—asthma	0.000295	0.00247	CbGeAlD
Crizotinib—ACVR1—lung—asthma	0.000295	0.00247	CbGeAlD
Crizotinib—EPHA4—adrenal gland—asthma	0.000294	0.00246	CbGeAlD
Crizotinib—SRC—smooth muscle tissue—asthma	0.000291	0.00243	CbGeAlD
Crizotinib—STK35—lung—asthma	0.000289	0.00242	CbGeAlD
Crizotinib—MAP3K2—adrenal gland—asthma	0.000288	0.00241	CbGeAlD
Crizotinib—EPHB6—trachea—asthma	0.000287	0.0024	CbGeAlD
Crizotinib—STK10—cardiovascular system—asthma	0.000285	0.00238	CbGeAlD
Crizotinib—TAOK3—cardiovascular system—asthma	0.000284	0.00237	CbGeAlD
Crizotinib—PTK2—adrenal gland—asthma	0.000282	0.00237	CbGeAlD
Crizotinib—TBK1—adrenal gland—asthma	0.000282	0.00237	CbGeAlD
Crizotinib—ABL2—lung—asthma	0.000282	0.00236	CbGeAlD
Crizotinib—TYK2—adrenal gland—asthma	0.000281	0.00235	CbGeAlD
Crizotinib—BMP2K—lung—asthma	0.000278	0.00233	CbGeAlD
Crizotinib—YES1—trachea—asthma	0.000277	0.00232	CbGeAlD
Crizotinib—IRAK1—adrenal gland—asthma	0.000277	0.00232	CbGeAlD
Crizotinib—SRC—cardiovascular system—asthma	0.000276	0.00231	CbGeAlD
Crizotinib—TAOK3—trachea—asthma	0.000274	0.00229	CbGeAlD
Crizotinib—CSF1R—adrenal cortex—asthma	0.000272	0.00228	CbGeAlD
Crizotinib—RPS6KB1—adrenal gland—asthma	0.000272	0.00228	CbGeAlD
Crizotinib—FGR—adrenal gland—asthma	0.00027	0.00226	CbGeAlD
Crizotinib—LCK—adrenal gland—asthma	0.00027	0.00226	CbGeAlD
Crizotinib—AXL—adrenal gland—asthma	0.000269	0.00225	CbGeAlD
Crizotinib—PTK2B—lung—asthma	0.000269	0.00225	CbGeAlD
Crizotinib—RIPK2—lung—asthma	0.000267	0.00223	CbGeAlD
Crizotinib—CSF1R—bronchus—asthma	0.000267	0.00223	CbGeAlD
Crizotinib—CSF1R—smooth muscle tissue—asthma	0.000261	0.00218	CbGeAlD
Crizotinib—SLK—adrenal gland—asthma	0.000259	0.00217	CbGeAlD
Crizotinib—EPHA4—lung—asthma	0.000258	0.00216	CbGeAlD
Crizotinib—EPHB4—adrenal gland—asthma	0.000257	0.00215	CbGeAlD
Crizotinib—ABL1—respiratory system—asthma	0.000256	0.00214	CbGeAlD
Crizotinib—JAK2—adrenal gland—asthma	0.000255	0.00214	CbGeAlD
Crizotinib—MAP3K2—lung—asthma	0.000253	0.00212	CbGeAlD
Crizotinib—EPHA2—adrenal gland—asthma	0.000252	0.00211	CbGeAlD
Crizotinib—CSF1R—cardiovascular system—asthma	0.000248	0.00208	CbGeAlD
Crizotinib—PTK2—lung—asthma	0.000248	0.00207	CbGeAlD
Crizotinib—TBK1—lung—asthma	0.000248	0.00207	CbGeAlD
Crizotinib—MAP3K3—adrenal gland—asthma	0.000246	0.00206	CbGeAlD
Crizotinib—TEK—adrenal gland—asthma	0.000246	0.00206	CbGeAlD
Crizotinib—MAP4K5—adrenal gland—asthma	0.000246	0.00206	CbGeAlD
Crizotinib—TYK2—lung—asthma	0.000246	0.00206	CbGeAlD
Crizotinib—IRAK1—lung—asthma	0.000243	0.00203	CbGeAlD
Crizotinib—CSF1R—trachea—asthma	0.000239	0.002	CbGeAlD
Crizotinib—RPS6KB1—lung—asthma	0.000238	0.00199	CbGeAlD
Crizotinib—FGR—lung—asthma	0.000237	0.00198	CbGeAlD
Crizotinib—LCK—lung—asthma	0.000237	0.00198	CbGeAlD
Crizotinib—AXL—lung—asthma	0.000236	0.00197	CbGeAlD
Crizotinib—EPHB6—adrenal gland—asthma	0.000235	0.00197	CbGeAlD
Crizotinib—YES1—adrenal gland—asthma	0.000227	0.0019	CbGeAlD
Crizotinib—SLK—lung—asthma	0.000227	0.0019	CbGeAlD
Crizotinib—EPHB4—lung—asthma	0.000225	0.00189	CbGeAlD
Crizotinib—STK10—adrenal gland—asthma	0.000225	0.00189	CbGeAlD
Crizotinib—TAOK3—adrenal gland—asthma	0.000224	0.00188	CbGeAlD
Crizotinib—JAK2—lung—asthma	0.000224	0.00187	CbGeAlD
Crizotinib—EPHA2—lung—asthma	0.000221	0.00185	CbGeAlD
Crizotinib—SRC—adrenal gland—asthma	0.000219	0.00183	CbGeAlD
Crizotinib—MAP3K3—lung—asthma	0.000216	0.00181	CbGeAlD
Crizotinib—MAP4K5—lung—asthma	0.000216	0.00181	CbGeAlD
Crizotinib—TEK—lung—asthma	0.000216	0.00181	CbGeAlD
Crizotinib—ABL1—adrenal cortex—asthma	0.000215	0.0018	CbGeAlD
Crizotinib—ABL1—bronchus—asthma	0.000211	0.00176	CbGeAlD
Crizotinib—ABL1—smooth muscle tissue—asthma	0.000206	0.00173	CbGeAlD
Crizotinib—EPHB6—lung—asthma	0.000206	0.00173	CbGeAlD
Crizotinib—YES1—lung—asthma	0.000199	0.00167	CbGeAlD
Crizotinib—STK10—lung—asthma	0.000197	0.00165	CbGeAlD
Crizotinib—TAOK3—lung—asthma	0.000197	0.00165	CbGeAlD
Crizotinib—CSF1R—adrenal gland—asthma	0.000196	0.00164	CbGeAlD
Crizotinib—ABL1—cardiovascular system—asthma	0.000196	0.00164	CbGeAlD
Crizotinib—SRC—lung—asthma	0.000192	0.0016	CbGeAlD
Crizotinib—ABL1—trachea—asthma	0.000189	0.00158	CbGeAlD
Crizotinib—CSF1R—lung—asthma	0.000172	0.00144	CbGeAlD
Crizotinib—PTK2B—Pindolol—Isoprenaline—asthma	0.000167	0.0428	CbGdCrCtD
Crizotinib—ABL1—adrenal gland—asthma	0.000155	0.0013	CbGeAlD
Crizotinib—CYP3A5—respiratory system—asthma	0.00015	0.00125	CbGeAlD
Crizotinib—ABL1—lung—asthma	0.000136	0.00114	CbGeAlD
Crizotinib—ACVR1—Dexamethasone—Fluticasone furoate—asthma	0.000134	0.0343	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Fluticasone furoate—asthma	0.000134	0.0343	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Fluticasone Propionate—asthma	0.000125	0.032	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Fluticasone Propionate—asthma	0.000125	0.032	CbGdCrCtD
Crizotinib—Asthenia—Flunisolide—asthma	0.00011	0.000795	CcSEcCtD
Crizotinib—Nausea—Fluticasone Propionate—asthma	0.00011	0.000795	CcSEcCtD
Crizotinib—Nausea—Salmeterol—asthma	0.00011	0.000793	CcSEcCtD
Crizotinib—Paraesthesia—Budesonide—asthma	0.00011	0.000792	CcSEcCtD
Crizotinib—Dizziness—Loratadine—asthma	0.00011	0.000792	CcSEcCtD
Crizotinib—Decreased appetite—Salbutamol—asthma	0.00011	0.000792	CcSEcCtD
Crizotinib—Dizziness—Tiotropium—asthma	0.000109	0.00079	CcSEcCtD
Crizotinib—Dyspnoea—Budesonide—asthma	0.000109	0.000786	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Salbutamol—asthma	0.000109	0.000786	CcSEcCtD
Crizotinib—Fatigue—Salbutamol—asthma	0.000109	0.000785	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Triamcinolone—asthma	0.000109	0.000785	CcSEcCtD
Crizotinib—Neuropathy peripheral—Hydrocortisone—asthma	0.000109	0.000784	CcSEcCtD
Crizotinib—Muscular weakness—Dexamethasone—asthma	0.000108	0.000782	CcSEcCtD
Crizotinib—Muscular weakness—Betamethasone—asthma	0.000108	0.000782	CcSEcCtD
Crizotinib—Constipation—Salbutamol—asthma	0.000108	0.000779	CcSEcCtD
Crizotinib—Dyspepsia—Budesonide—asthma	0.000108	0.000777	CcSEcCtD
Crizotinib—Decreased appetite—Budesonide—asthma	0.000106	0.000767	CcSEcCtD
Crizotinib—Body temperature increased—Formoterol—asthma	0.000106	0.000762	CcSEcCtD
Crizotinib—Body temperature increased—Arformoterol—asthma	0.000106	0.000762	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Budesonide—asthma	0.000106	0.000762	CcSEcCtD
Crizotinib—Vomiting—Loratadine—asthma	0.000105	0.000761	CcSEcCtD
Crizotinib—Fatigue—Budesonide—asthma	0.000105	0.000761	CcSEcCtD
Crizotinib—Vomiting—Tiotropium—asthma	0.000105	0.00076	CcSEcCtD
Crizotinib—Diarrhoea—Flunisolide—asthma	0.000105	0.000758	CcSEcCtD
Crizotinib—Rash—Loratadine—asthma	0.000105	0.000755	CcSEcCtD
Crizotinib—Constipation—Budesonide—asthma	0.000105	0.000754	CcSEcCtD
Crizotinib—Dermatitis—Loratadine—asthma	0.000104	0.000754	CcSEcCtD
Crizotinib—Rash—Tiotropium—asthma	0.000104	0.000754	CcSEcCtD
Crizotinib—Dermatitis—Tiotropium—asthma	0.000104	0.000753	CcSEcCtD
Crizotinib—Nausea—Aminophylline—asthma	0.000104	0.000753	CcSEcCtD
Crizotinib—Infestation NOS—Methylprednisolone—asthma	0.000104	0.000751	CcSEcCtD
Crizotinib—Infestation—Methylprednisolone—asthma	0.000104	0.000751	CcSEcCtD
Crizotinib—Bradycardia—Prednisolone—asthma	0.000104	0.000748	CcSEcCtD
Crizotinib—Body temperature increased—Montelukast—asthma	0.000103	0.000747	CcSEcCtD
Crizotinib—Face oedema—Prednisone—asthma	0.000103	0.000746	CcSEcCtD
Crizotinib—Neuropathy peripheral—Triamcinolone—asthma	0.000102	0.000738	CcSEcCtD
Crizotinib—Asthenia—Mometasone—asthma	0.000102	0.000737	CcSEcCtD
Crizotinib—Neuropathy peripheral—Methylprednisolone—asthma	0.000102	0.000737	CcSEcCtD
Crizotinib—Dizziness—Flunisolide—asthma	0.000101	0.000733	CcSEcCtD
Crizotinib—Bradycardia—Hydrocortisone—asthma	0.000101	0.000731	CcSEcCtD
Crizotinib—Body temperature increased—Salbutamol—asthma	9.97e-05	0.00072	CcSEcCtD
Crizotinib—Nausea—Loratadine—asthma	9.85e-05	0.000711	CcSEcCtD
Crizotinib—Nausea—Tiotropium—asthma	9.83e-05	0.00071	CcSEcCtD
Crizotinib—Visual impairment—Prednisolone—asthma	9.82e-05	0.000709	CcSEcCtD
Crizotinib—Vomiting—Flunisolide—asthma	9.76e-05	0.000704	CcSEcCtD
Crizotinib—Diarrhoea—Mometasone—asthma	9.74e-05	0.000703	CcSEcCtD
Crizotinib—Hypokalaemia—Prednisone—asthma	9.74e-05	0.000703	CcSEcCtD
Crizotinib—Rash—Flunisolide—asthma	9.68e-05	0.000698	CcSEcCtD
Crizotinib—Dermatitis—Flunisolide—asthma	9.67e-05	0.000698	CcSEcCtD
Crizotinib—Body temperature increased—Budesonide—asthma	9.66e-05	0.000697	CcSEcCtD
Crizotinib—Weight decreased—Betamethasone—asthma	9.61e-05	0.000693	CcSEcCtD
Crizotinib—Weight decreased—Dexamethasone—asthma	9.61e-05	0.000693	CcSEcCtD
Crizotinib—Asthenia—Formoterol—asthma	9.59e-05	0.000692	CcSEcCtD
Crizotinib—Asthenia—Arformoterol—asthma	9.59e-05	0.000692	CcSEcCtD
Crizotinib—Bradycardia—Triamcinolone—asthma	9.54e-05	0.000688	CcSEcCtD
Crizotinib—Bradycardia—Methylprednisolone—asthma	9.51e-05	0.000687	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Prednisone—asthma	9.44e-05	0.000681	CcSEcCtD
Crizotinib—Muscular weakness—Prednisone—asthma	9.44e-05	0.000681	CcSEcCtD
Crizotinib—Asthenia—Montelukast—asthma	9.39e-05	0.000678	CcSEcCtD
Crizotinib—Eye disorder—Hydrocortisone—asthma	9.3e-05	0.000671	CcSEcCtD
Crizotinib—Neuropathy peripheral—Dexamethasone—asthma	9.28e-05	0.00067	CcSEcCtD
Crizotinib—Neuropathy peripheral—Betamethasone—asthma	9.28e-05	0.00067	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Beclomethasone—asthma	9.21e-05	0.0235	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Beclomethasone—asthma	9.21e-05	0.0235	CbGdCrCtD
Crizotinib—Diarrhoea—Formoterol—asthma	9.14e-05	0.00066	CcSEcCtD
Crizotinib—Diarrhoea—Arformoterol—asthma	9.14e-05	0.00066	CcSEcCtD
Crizotinib—Nausea—Flunisolide—asthma	9.12e-05	0.000658	CcSEcCtD
Crizotinib—Arrhythmia—Prednisolone—asthma	9.1e-05	0.000657	CcSEcCtD
Crizotinib—Asthenia—Salbutamol—asthma	9.05e-05	0.000653	CcSEcCtD
Crizotinib—Vomiting—Mometasone—asthma	9.05e-05	0.000653	CcSEcCtD
Crizotinib—Visual impairment—Methylprednisolone—asthma	9.01e-05	0.00065	CcSEcCtD
Crizotinib—Rash—Mometasone—asthma	8.98e-05	0.000648	CcSEcCtD
Crizotinib—Dermatitis—Mometasone—asthma	8.97e-05	0.000647	CcSEcCtD
Crizotinib—Diarrhoea—Montelukast—asthma	8.96e-05	0.000646	CcSEcCtD
Crizotinib—Arrhythmia—Hydrocortisone—asthma	8.89e-05	0.000641	CcSEcCtD
Crizotinib—Dizziness—Arformoterol—asthma	8.84e-05	0.000638	CcSEcCtD
Crizotinib—Dizziness—Formoterol—asthma	8.84e-05	0.000638	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Budesonide—asthma	8.83e-05	0.0226	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Budesonide—asthma	8.83e-05	0.0226	CbGdCrCtD
Crizotinib—Asthenia—Budesonide—asthma	8.77e-05	0.000633	CcSEcCtD
Crizotinib—Eye disorder—Methylprednisolone—asthma	8.73e-05	0.00063	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Flunisolide—asthma	8.72e-05	0.0223	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Flunisolide—asthma	8.72e-05	0.0223	CbGdCrCtD
Crizotinib—Cardiac disorder—Methylprednisolone—asthma	8.67e-05	0.000626	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Fluticasone furoate—asthma	8.66e-05	0.0221	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Fluticasone furoate—asthma	8.66e-05	0.0221	CbGdCrCtD
Crizotinib—Malnutrition—Hydrocortisone—asthma	8.66e-05	0.000625	CcSEcCtD
Crizotinib—Dizziness—Montelukast—asthma	8.66e-05	0.000625	CcSEcCtD
Crizotinib—Bradycardia—Dexamethasone—asthma	8.65e-05	0.000625	CcSEcCtD
Crizotinib—Bradycardia—Betamethasone—asthma	8.65e-05	0.000625	CcSEcCtD
Crizotinib—Neutropenia—Prednisone—asthma	8.65e-05	0.000624	CcSEcCtD
Crizotinib—Diarrhoea—Salbutamol—asthma	8.63e-05	0.000623	CcSEcCtD
Crizotinib—Vomiting—Arformoterol—asthma	8.5e-05	0.000613	CcSEcCtD
Crizotinib—Vomiting—Formoterol—asthma	8.5e-05	0.000613	CcSEcCtD
Crizotinib—Nausea—Mometasone—asthma	8.46e-05	0.00061	CcSEcCtD
Crizotinib—Rash—Formoterol—asthma	8.43e-05	0.000608	CcSEcCtD
Crizotinib—Rash—Arformoterol—asthma	8.43e-05	0.000608	CcSEcCtD
Crizotinib—Mediastinal disorder—Methylprednisolone—asthma	8.42e-05	0.000608	CcSEcCtD
Crizotinib—Dermatitis—Formoterol—asthma	8.42e-05	0.000608	CcSEcCtD
Crizotinib—Dermatitis—Arformoterol—asthma	8.42e-05	0.000608	CcSEcCtD
Crizotinib—Arrhythmia—Triamcinolone—asthma	8.37e-05	0.000604	CcSEcCtD
Crizotinib—Weight decreased—Prednisone—asthma	8.37e-05	0.000604	CcSEcCtD
Crizotinib—Diarrhoea—Budesonide—asthma	8.36e-05	0.000604	CcSEcCtD
Crizotinib—Vision blurred—Prednisolone—asthma	8.36e-05	0.000603	CcSEcCtD
Crizotinib—Arrhythmia—Methylprednisolone—asthma	8.35e-05	0.000603	CcSEcCtD
Crizotinib—Dizziness—Salbutamol—asthma	8.34e-05	0.000602	CcSEcCtD
Crizotinib—Vomiting—Montelukast—asthma	8.32e-05	0.000601	CcSEcCtD
Crizotinib—Rash—Montelukast—asthma	8.25e-05	0.000596	CcSEcCtD
Crizotinib—Dermatitis—Montelukast—asthma	8.24e-05	0.000595	CcSEcCtD
Crizotinib—Visual impairment—Dexamethasone—asthma	8.19e-05	0.000591	CcSEcCtD
Crizotinib—Visual impairment—Betamethasone—asthma	8.19e-05	0.000591	CcSEcCtD
Crizotinib—Malnutrition—Methylprednisolone—asthma	8.14e-05	0.000587	CcSEcCtD
Crizotinib—Neuropathy peripheral—Prednisone—asthma	8.08e-05	0.000583	CcSEcCtD
Crizotinib—Dizziness—Budesonide—asthma	8.08e-05	0.000583	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Fluticasone Propionate—asthma	8.08e-05	0.0206	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Fluticasone Propionate—asthma	8.08e-05	0.0206	CbGdCrCtD
Crizotinib—Vomiting—Salbutamol—asthma	8.02e-05	0.000579	CcSEcCtD
Crizotinib—Dysgeusia—Triamcinolone—asthma	7.99e-05	0.000576	CcSEcCtD
Crizotinib—ABCB1—respiratory system—asthma	7.96e-05	0.000667	CbGeAlD
Crizotinib—CYP3A5—lung—asthma	7.96e-05	0.000666	CbGeAlD
Crizotinib—Rash—Salbutamol—asthma	7.96e-05	0.000574	CcSEcCtD
Crizotinib—Syncope—Prednisolone—asthma	7.95e-05	0.000574	CcSEcCtD
Crizotinib—Dermatitis—Salbutamol—asthma	7.95e-05	0.000574	CcSEcCtD
Crizotinib—Eye disorder—Betamethasone—asthma	7.94e-05	0.000573	CcSEcCtD
Crizotinib—Eye disorder—Dexamethasone—asthma	7.94e-05	0.000573	CcSEcCtD
Crizotinib—Nausea—Formoterol—asthma	7.94e-05	0.000573	CcSEcCtD
Crizotinib—Nausea—Arformoterol—asthma	7.94e-05	0.000573	CcSEcCtD
Crizotinib—Loss of consciousness—Prednisolone—asthma	7.79e-05	0.000563	CcSEcCtD
Crizotinib—Nausea—Montelukast—asthma	7.77e-05	0.000561	CcSEcCtD
Crizotinib—Vomiting—Budesonide—asthma	7.77e-05	0.000561	CcSEcCtD
Crizotinib—Syncope—Hydrocortisone—asthma	7.77e-05	0.000561	CcSEcCtD
Crizotinib—Rash—Budesonide—asthma	7.71e-05	0.000556	CcSEcCtD
Crizotinib—Dermatitis—Budesonide—asthma	7.7e-05	0.000556	CcSEcCtD
Crizotinib—Loss of consciousness—Hydrocortisone—asthma	7.61e-05	0.000549	CcSEcCtD
Crizotinib—Arrhythmia—Dexamethasone—asthma	7.59e-05	0.000548	CcSEcCtD
Crizotinib—Arrhythmia—Betamethasone—asthma	7.59e-05	0.000548	CcSEcCtD
Crizotinib—Bradycardia—Prednisone—asthma	7.54e-05	0.000544	CcSEcCtD
Crizotinib—Nausea—Salbutamol—asthma	7.49e-05	0.000541	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	7.32e-05	0.000528	CcSEcCtD
Crizotinib—Syncope—Triamcinolone—asthma	7.31e-05	0.000528	CcSEcCtD
Crizotinib—Syncope—Methylprednisolone—asthma	7.3e-05	0.000527	CcSEcCtD
Crizotinib—Nausea—Budesonide—asthma	7.26e-05	0.000524	CcSEcCtD
Crizotinib—Oedema—Prednisolone—asthma	7.24e-05	0.000522	CcSEcCtD
Crizotinib—Loss of consciousness—Triamcinolone—asthma	7.17e-05	0.000517	CcSEcCtD
Crizotinib—Loss of consciousness—Methylprednisolone—asthma	7.15e-05	0.000516	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Mometasone—asthma	7.14e-05	0.0183	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Mometasone—asthma	7.14e-05	0.0183	CbGdCrCtD
Crizotinib—Shock—Prednisolone—asthma	7.12e-05	0.000514	CcSEcCtD
Crizotinib—Oedema—Hydrocortisone—asthma	7.07e-05	0.00051	CcSEcCtD
Crizotinib—Infection—Hydrocortisone—asthma	7.02e-05	0.000507	CcSEcCtD
Crizotinib—Shock—Hydrocortisone—asthma	6.95e-05	0.000502	CcSEcCtD
Crizotinib—Nervous system disorder—Hydrocortisone—asthma	6.93e-05	0.0005	CcSEcCtD
Crizotinib—Eye disorder—Prednisone—asthma	6.92e-05	0.000499	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	6.88e-05	0.000497	CcSEcCtD
Crizotinib—Skin disorder—Hydrocortisone—asthma	6.87e-05	0.000496	CcSEcCtD
Crizotinib—ABCB1—adrenal cortex—asthma	6.68e-05	0.00056	CbGeAlD
Crizotinib—Oedema—Triamcinolone—asthma	6.66e-05	0.00048	CcSEcCtD
Crizotinib—ABCB1—epithelium—asthma	6.65e-05	0.000557	CbGeAlD
Crizotinib—Syncope—Betamethasone—asthma	6.64e-05	0.000479	CcSEcCtD
Crizotinib—Syncope—Dexamethasone—asthma	6.64e-05	0.000479	CcSEcCtD
Crizotinib—Arrhythmia—Prednisone—asthma	6.61e-05	0.000477	CcSEcCtD
Crizotinib—Infection—Triamcinolone—asthma	6.61e-05	0.000477	CcSEcCtD
Crizotinib—Infection—Methylprednisolone—asthma	6.6e-05	0.000476	CcSEcCtD
Crizotinib—Shock—Triamcinolone—asthma	6.55e-05	0.000473	CcSEcCtD
Crizotinib—Shock—Methylprednisolone—asthma	6.53e-05	0.000472	CcSEcCtD
Crizotinib—Nervous system disorder—Methylprednisolone—asthma	6.51e-05	0.00047	CcSEcCtD
Crizotinib—Loss of consciousness—Dexamethasone—asthma	6.5e-05	0.000469	CcSEcCtD
Crizotinib—Loss of consciousness—Betamethasone—asthma	6.5e-05	0.000469	CcSEcCtD
Crizotinib—Paraesthesia—Prednisolone—asthma	6.5e-05	0.000469	CcSEcCtD
Crizotinib—Skin disorder—Methylprednisolone—asthma	6.45e-05	0.000466	CcSEcCtD
Crizotinib—Malnutrition—Prednisone—asthma	6.44e-05	0.000465	CcSEcCtD
Crizotinib—Paraesthesia—Hydrocortisone—asthma	6.35e-05	0.000458	CcSEcCtD
Crizotinib—Dyspepsia—Hydrocortisone—asthma	6.22e-05	0.000449	CcSEcCtD
Crizotinib—Decreased appetite—Hydrocortisone—asthma	6.14e-05	0.000443	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Hydrocortisone—asthma	6.1e-05	0.00044	CcSEcCtD
Crizotinib—ABCB1—cardiovascular system—asthma	6.1e-05	0.000511	CbGeAlD
Crizotinib—Fatigue—Hydrocortisone—asthma	6.09e-05	0.00044	CcSEcCtD
Crizotinib—Vision blurred—Prednisone—asthma	6.07e-05	0.000438	CcSEcCtD
Crizotinib—Oedema—Dexamethasone—asthma	6.04e-05	0.000436	CcSEcCtD
Crizotinib—Oedema—Betamethasone—asthma	6.04e-05	0.000436	CcSEcCtD
Crizotinib—Infection—Betamethasone—asthma	6e-05	0.000433	CcSEcCtD
Crizotinib—Infection—Dexamethasone—asthma	6e-05	0.000433	CcSEcCtD
Crizotinib—Paraesthesia—Triamcinolone—asthma	5.98e-05	0.000431	CcSEcCtD
Crizotinib—Paraesthesia—Methylprednisolone—asthma	5.96e-05	0.00043	CcSEcCtD
Crizotinib—Anaemia—Prednisone—asthma	5.96e-05	0.00043	CcSEcCtD
Crizotinib—Shock—Betamethasone—asthma	5.94e-05	0.000429	CcSEcCtD
Crizotinib—Shock—Dexamethasone—asthma	5.94e-05	0.000429	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Beclomethasone—asthma	5.94e-05	0.0152	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Beclomethasone—asthma	5.94e-05	0.0152	CbGdCrCtD
Crizotinib—Dyspnoea—Triamcinolone—asthma	5.93e-05	0.000428	CcSEcCtD
Crizotinib—Nervous system disorder—Betamethasone—asthma	5.92e-05	0.000427	CcSEcCtD
Crizotinib—Nervous system disorder—Dexamethasone—asthma	5.92e-05	0.000427	CcSEcCtD
Crizotinib—ABCB1—trachea—asthma	5.88e-05	0.000493	CbGeAlD
Crizotinib—Dyspepsia—Triamcinolone—asthma	5.86e-05	0.000423	CcSEcCtD
Crizotinib—Dyspepsia—Methylprednisolone—asthma	5.85e-05	0.000422	CcSEcCtD
Crizotinib—Syncope—Prednisone—asthma	5.78e-05	0.000417	CcSEcCtD
Crizotinib—Fatigue—Triamcinolone—asthma	5.74e-05	0.000414	CcSEcCtD
Crizotinib—Fatigue—Methylprednisolone—asthma	5.72e-05	0.000413	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Budesonide—asthma	5.69e-05	0.0145	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Budesonide—asthma	5.69e-05	0.0145	CbGdCrCtD
Crizotinib—Loss of consciousness—Prednisone—asthma	5.66e-05	0.000409	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Flunisolide—asthma	5.62e-05	0.0144	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Flunisolide—asthma	5.62e-05	0.0144	CbGdCrCtD
Crizotinib—Body temperature increased—Hydrocortisone—asthma	5.59e-05	0.000403	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	5.45e-05	0.000393	CcSEcCtD
Crizotinib—Paraesthesia—Betamethasone—asthma	5.42e-05	0.000391	CcSEcCtD
Crizotinib—Paraesthesia—Dexamethasone—asthma	5.42e-05	0.000391	CcSEcCtD
Crizotinib—Dyspepsia—Betamethasone—asthma	5.32e-05	0.000384	CcSEcCtD
Crizotinib—Dyspepsia—Dexamethasone—asthma	5.32e-05	0.000384	CcSEcCtD
Crizotinib—Body temperature increased—Triamcinolone—asthma	5.26e-05	0.00038	CcSEcCtD
Crizotinib—Oedema—Prednisone—asthma	5.26e-05	0.00038	CcSEcCtD
Crizotinib—Decreased appetite—Betamethasone—asthma	5.25e-05	0.000379	CcSEcCtD
Crizotinib—Decreased appetite—Dexamethasone—asthma	5.25e-05	0.000379	CcSEcCtD
Crizotinib—Infection—Prednisone—asthma	5.22e-05	0.000377	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Betamethasone—asthma	5.21e-05	0.000376	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Dexamethasone—asthma	5.21e-05	0.000376	CcSEcCtD
Crizotinib—Fatigue—Dexamethasone—asthma	5.21e-05	0.000376	CcSEcCtD
Crizotinib—Fatigue—Betamethasone—asthma	5.21e-05	0.000376	CcSEcCtD
Crizotinib—Shock—Prednisone—asthma	5.17e-05	0.000373	CcSEcCtD
Crizotinib—Nervous system disorder—Prednisone—asthma	5.16e-05	0.000372	CcSEcCtD
Crizotinib—Skin disorder—Prednisone—asthma	5.11e-05	0.000369	CcSEcCtD
Crizotinib—Asthenia—Hydrocortisone—asthma	5.07e-05	0.000366	CcSEcCtD
Crizotinib—Diarrhoea—Hydrocortisone—asthma	4.84e-05	0.000349	CcSEcCtD
Crizotinib—ABCB1—adrenal gland—asthma	4.82e-05	0.000404	CbGeAlD
Crizotinib—Dizziness—Prednisolone—asthma	4.79e-05	0.000345	CcSEcCtD
Crizotinib—Asthenia—Triamcinolone—asthma	4.77e-05	0.000345	CcSEcCtD
Crizotinib—Body temperature increased—Dexamethasone—asthma	4.77e-05	0.000345	CcSEcCtD
Crizotinib—Body temperature increased—Betamethasone—asthma	4.77e-05	0.000345	CcSEcCtD
Crizotinib—Asthenia—Methylprednisolone—asthma	4.76e-05	0.000344	CcSEcCtD
Crizotinib—Paraesthesia—Prednisone—asthma	4.72e-05	0.000341	CcSEcCtD
Crizotinib—Dizziness—Hydrocortisone—asthma	4.67e-05	0.000337	CcSEcCtD
Crizotinib—Dyspepsia—Prednisone—asthma	4.63e-05	0.000334	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Mometasone—asthma	4.6e-05	0.0118	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Mometasone—asthma	4.6e-05	0.0118	CbGdCrCtD
Crizotinib—Decreased appetite—Prednisone—asthma	4.57e-05	0.00033	CcSEcCtD
Crizotinib—Rash—Prednisolone—asthma	4.56e-05	0.000329	CcSEcCtD
Crizotinib—Dermatitis—Prednisolone—asthma	4.56e-05	0.000329	CcSEcCtD
Crizotinib—Diarrhoea—Methylprednisolone—asthma	4.54e-05	0.000328	CcSEcCtD
Crizotinib—Fatigue—Prednisone—asthma	4.53e-05	0.000327	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Hydrocortisone—asthma	4.52e-05	0.0116	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Hydrocortisone—asthma	4.52e-05	0.0116	CbGdCrCtD
Crizotinib—Constipation—Prednisone—asthma	4.5e-05	0.000325	CcSEcCtD
Crizotinib—Vomiting—Hydrocortisone—asthma	4.49e-05	0.000324	CcSEcCtD
Crizotinib—Rash—Hydrocortisone—asthma	4.46e-05	0.000322	CcSEcCtD
Crizotinib—Dermatitis—Hydrocortisone—asthma	4.45e-05	0.000321	CcSEcCtD
Crizotinib—Dizziness—Triamcinolone—asthma	4.4e-05	0.000318	CcSEcCtD
Crizotinib—Dizziness—Methylprednisolone—asthma	4.39e-05	0.000317	CcSEcCtD
Crizotinib—Asthenia—Betamethasone—asthma	4.33e-05	0.000313	CcSEcCtD
Crizotinib—Asthenia—Dexamethasone—asthma	4.33e-05	0.000313	CcSEcCtD
Crizotinib—Nausea—Prednisolone—asthma	4.3e-05	0.00031	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Methylprednisolone—asthma	4.27e-05	0.0109	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Methylprednisolone—asthma	4.27e-05	0.0109	CbGdCrCtD
Crizotinib—Vomiting—Triamcinolone—asthma	4.23e-05	0.000305	CcSEcCtD
Crizotinib—ABCB1—lung—asthma	4.23e-05	0.000354	CbGeAlD
Crizotinib—Vomiting—Methylprednisolone—asthma	4.22e-05	0.000305	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Betamethasone—asthma	4.2e-05	0.0107	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Dexamethasone—asthma	4.2e-05	0.0107	CbGdCrCtD
Crizotinib—Nausea—Hydrocortisone—asthma	4.2e-05	0.000303	CcSEcCtD
Crizotinib—Rash—Triamcinolone—asthma	4.2e-05	0.000303	CcSEcCtD
Crizotinib—Dermatitis—Triamcinolone—asthma	4.19e-05	0.000303	CcSEcCtD
Crizotinib—Rash—Methylprednisolone—asthma	4.19e-05	0.000302	CcSEcCtD
Crizotinib—Dermatitis—Methylprednisolone—asthma	4.18e-05	0.000302	CcSEcCtD
Crizotinib—Body temperature increased—Prednisone—asthma	4.16e-05	0.0003	CcSEcCtD
Crizotinib—Diarrhoea—Betamethasone—asthma	4.13e-05	0.000298	CcSEcCtD
Crizotinib—Diarrhoea—Dexamethasone—asthma	4.13e-05	0.000298	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Triamcinolone—asthma	4.1e-05	0.0105	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Triamcinolone—asthma	4.1e-05	0.0105	CbGdCrCtD
Crizotinib—Dizziness—Dexamethasone—asthma	3.99e-05	0.000288	CcSEcCtD
Crizotinib—Dizziness—Betamethasone—asthma	3.99e-05	0.000288	CcSEcCtD
Crizotinib—Nausea—Triamcinolone—asthma	3.95e-05	0.000285	CcSEcCtD
Crizotinib—Nausea—Methylprednisolone—asthma	3.94e-05	0.000285	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Prednisone—asthma	3.89e-05	0.00995	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Prednisone—asthma	3.89e-05	0.00995	CbGdCrCtD
Crizotinib—Vomiting—Betamethasone—asthma	3.84e-05	0.000277	CcSEcCtD
Crizotinib—Vomiting—Dexamethasone—asthma	3.84e-05	0.000277	CcSEcCtD
Crizotinib—Rash—Dexamethasone—asthma	3.81e-05	0.000275	CcSEcCtD
Crizotinib—Rash—Betamethasone—asthma	3.81e-05	0.000275	CcSEcCtD
Crizotinib—Dermatitis—Betamethasone—asthma	3.8e-05	0.000275	CcSEcCtD
Crizotinib—Dermatitis—Dexamethasone—asthma	3.8e-05	0.000275	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Prednisolone—asthma	3.8e-05	0.00971	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Prednisolone—asthma	3.8e-05	0.00971	CbGdCrCtD
Crizotinib—Asthenia—Prednisone—asthma	3.77e-05	0.000272	CcSEcCtD
Crizotinib—Diarrhoea—Prednisone—asthma	3.6e-05	0.00026	CcSEcCtD
Crizotinib—Nausea—Betamethasone—asthma	3.59e-05	0.000259	CcSEcCtD
Crizotinib—Nausea—Dexamethasone—asthma	3.59e-05	0.000259	CcSEcCtD
Crizotinib—Dizziness—Prednisone—asthma	3.48e-05	0.000251	CcSEcCtD
Crizotinib—Vomiting—Prednisone—asthma	3.34e-05	0.000241	CcSEcCtD
Crizotinib—Rash—Prednisone—asthma	3.32e-05	0.000239	CcSEcCtD
Crizotinib—Dermatitis—Prednisone—asthma	3.31e-05	0.000239	CcSEcCtD
Crizotinib—Nausea—Prednisone—asthma	3.12e-05	0.000225	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Hydrocortisone—asthma	2.91e-05	0.00745	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Hydrocortisone—asthma	2.91e-05	0.00745	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Methylprednisolone—asthma	2.75e-05	0.00703	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Methylprednisolone—asthma	2.75e-05	0.00703	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Betamethasone—asthma	2.71e-05	0.00691	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Dexamethasone—asthma	2.71e-05	0.00691	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Triamcinolone—asthma	2.64e-05	0.00676	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Triamcinolone—asthma	2.64e-05	0.00676	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Prednisone—asthma	2.51e-05	0.00641	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Prednisone—asthma	2.51e-05	0.00641	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Prednisolone—asthma	2.45e-05	0.00626	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Prednisolone—asthma	2.45e-05	0.00626	CbGdCrCtD
Crizotinib—LCK—Immune System—BCL2—asthma	1.16e-06	5.9e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—STAT3—asthma	1.15e-06	5.89e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—asthma	1.14e-06	5.85e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CXCL8—asthma	1.14e-06	5.83e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCR5—asthma	1.14e-06	5.81e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GSTP1—asthma	1.14e-06	5.81e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CD86—asthma	1.14e-06	5.8e-06	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—EGFR—asthma	1.14e-06	5.8e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EDN1—asthma	1.13e-06	5.76e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CXCL8—asthma	1.13e-06	5.75e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL2RA—asthma	1.12e-06	5.73e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—HMOX1—asthma	1.12e-06	5.73e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—RHOA—asthma	1.12e-06	5.72e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ITPR1—asthma	1.12e-06	5.71e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL5—asthma	1.12e-06	5.71e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—FN1—asthma	1.12e-06	5.7e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—VEGFA—asthma	1.11e-06	5.69e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PLA2G4A—asthma	1.11e-06	5.69e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—C3—asthma	1.11e-06	5.68e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS3—asthma	1.11e-06	5.66e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CAT—asthma	1.11e-06	5.65e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—asthma	1.11e-06	5.65e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—STAT3—asthma	1.1e-06	5.64e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—asthma	1.1e-06	5.64e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CSF2—asthma	1.1e-06	5.63e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6R—asthma	1.1e-06	5.6e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PTEN—asthma	1.09e-06	5.58e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL2—asthma	1.09e-06	5.57e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—POMC—asthma	1.09e-06	5.54e-06	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	1.08e-06	5.54e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—asthma	1.08e-06	5.54e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PDGFB—asthma	1.08e-06	5.53e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—EGFR—asthma	1.08e-06	5.53e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—VEGFA—asthma	1.08e-06	5.52e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL2—asthma	1.08e-06	5.5e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SMAD3—asthma	1.07e-06	5.48e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—STAT3—asthma	1.07e-06	5.47e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—asthma	1.07e-06	5.46e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CXCL8—asthma	1.07e-06	5.45e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—EGFR—asthma	1.06e-06	5.43e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL2—asthma	1.06e-06	5.42e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6R—asthma	1.06e-06	5.41e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—EGFR—asthma	1.05e-06	5.35e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PLA2G4A—asthma	1.04e-06	5.34e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GSTM1—asthma	1.04e-06	5.34e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—STAT3—asthma	1.04e-06	5.33e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—STAT3—asthma	1.04e-06	5.31e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CXCL8—asthma	1.04e-06	5.3e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—LEP—asthma	1.04e-06	5.29e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—MMP9—asthma	1.03e-06	5.27e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALOX15—asthma	1.03e-06	5.27e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALOX5AP—asthma	1.03e-06	5.27e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—asthma	1.03e-06	5.26e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NQO1—asthma	1.03e-06	5.25e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—SERPINE1—asthma	1.03e-06	5.25e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—PTEN—asthma	1.03e-06	5.24e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—asthma	1.03e-06	5.24e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PPP2CA—asthma	1.03e-06	5.24e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—asthma	1.02e-06	5.23e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—BCL2—asthma	1.02e-06	5.22e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—asthma	1.02e-06	5.22e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—asthma	1.02e-06	5.21e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL2—asthma	1.02e-06	5.21e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—MMP9—asthma	1.02e-06	5.2e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL2—asthma	1.02e-06	5.2e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—POMC—asthma	1.02e-06	5.19e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—asthma	1.01e-06	5.18e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTGS2—asthma	1.01e-06	5.18e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—PTEN—asthma	1.01e-06	5.17e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—PTEN—asthma	1.01e-06	5.15e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCR5—asthma	1.01e-06	5.15e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ADCY2—asthma	1.01e-06	5.14e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—EGFR—asthma	1e-06	5.12e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL2—asthma	9.94e-07	5.08e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL2RA—asthma	9.93e-07	5.07e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—asthma	9.92e-07	5.07e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—asthma	9.92e-07	5.07e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SERPINE1—asthma	9.91e-07	5.06e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—RHOA—asthma	9.91e-07	5.06e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6R—asthma	9.91e-07	5.06e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL2—asthma	9.91e-07	5.06e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—asthma	9.86e-07	5.04e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—C3—asthma	9.85e-07	5.03e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CHAT—asthma	9.83e-07	5.02e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS3—asthma	9.81e-07	5.01e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—asthma	9.79e-07	5e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—asthma	9.78e-07	5e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—STAT3—asthma	9.77e-07	4.99e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FN1—asthma	9.77e-07	4.99e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—EGFR—asthma	9.73e-07	4.97e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—EGFR—asthma	9.72e-07	4.97e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—MMP9—asthma	9.66e-07	4.93e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PPP2CA—asthma	9.62e-07	4.91e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—PTEN—asthma	9.6e-07	4.91e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PDGFB—asthma	9.58e-07	4.9e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—PTEN—asthma	9.57e-07	4.89e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—RHOA—asthma	9.56e-07	4.88e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—EGFR—asthma	9.49e-07	4.85e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NOS3—asthma	9.47e-07	4.83e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—EGFR—asthma	9.45e-07	4.83e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—MMP9—asthma	9.38e-07	4.79e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—PTEN—asthma	9.32e-07	4.76e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—asthma	9.28e-07	4.74e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SERPINE1—asthma	9.28e-07	4.74e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—VEGFA—asthma	9.27e-07	4.74e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—STAT3—asthma	9.18e-07	4.69e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—asthma	9.17e-07	4.68e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—LEP—asthma	9.17e-07	4.68e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—VEGFA—asthma	9.15e-07	4.67e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—asthma	9.09e-07	4.64e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—STAT3—asthma	9.06e-07	4.63e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—asthma	9.04e-07	4.62e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—asthma	9.04e-07	4.62e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—STAT3—asthma	9.02e-07	4.61e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—asthma	9.01e-07	4.6e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL2—asthma	9.01e-07	4.6e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTGS2—asthma	8.97e-07	4.58e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—RHOA—asthma	8.95e-07	4.57e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—POMC—asthma	8.9e-07	4.54e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—EGFR—asthma	8.88e-07	4.54e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NOS3—asthma	8.86e-07	4.52e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—PTEN—asthma	8.84e-07	4.51e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALOX5—asthma	8.77e-07	4.48e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL2—asthma	8.7e-07	4.45e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6R—asthma	8.68e-07	4.43e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—VEGFA—asthma	8.67e-07	4.43e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FN1—asthma	8.65e-07	4.42e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—STAT3—asthma	8.59e-07	4.39e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTP1—asthma	8.58e-07	4.38e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—STAT3—asthma	8.56e-07	4.37e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—asthma	8.51e-07	4.35e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—PTEN—asthma	8.47e-07	4.33e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HMOX1—asthma	8.46e-07	4.32e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ITPR1—asthma	8.44e-07	4.31e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—VEGFA—asthma	8.42e-07	4.3e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CXCL8—asthma	8.4e-07	4.29e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—asthma	8.39e-07	4.29e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—asthma	8.36e-07	4.27e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CARM1—asthma	8.36e-07	4.27e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CAT—asthma	8.35e-07	4.26e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—EGFR—asthma	8.35e-07	4.26e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—STAT3—asthma	8.34e-07	4.26e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—asthma	8.32e-07	4.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DCN—asthma	8.24e-07	4.21e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—EGFR—asthma	8.23e-07	4.2e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—EGFR—asthma	8.2e-07	4.19e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—asthma	8.17e-07	4.17e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SERPINE1—asthma	8.13e-07	4.15e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—asthma	8.06e-07	4.11e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL2—asthma	8.02e-07	4.1e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALDH2—asthma	8.02e-07	4.09e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—asthma	7.96e-07	4.07e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—STAT3—asthma	7.9e-07	4.04e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PLA2G4A—asthma	7.88e-07	4.03e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTM1—asthma	7.88e-07	4.03e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—POMC—asthma	7.88e-07	4.02e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CXCL8—asthma	7.86e-07	4.01e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—RHOA—asthma	7.84e-07	4e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—PTEN—asthma	7.82e-07	4e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—EGFR—asthma	7.81e-07	3.99e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—EGFR—asthma	7.78e-07	3.97e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NOS3—asthma	7.76e-07	3.96e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—asthma	7.73e-07	3.95e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—asthma	7.71e-07	3.94e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL2—asthma	7.71e-07	3.94e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6R—asthma	7.68e-07	3.92e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTT1—asthma	7.63e-07	3.9e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—MMP9—asthma	7.59e-07	3.88e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—STAT3—asthma	7.58e-07	3.87e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—EGFR—asthma	7.58e-07	3.87e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PTEN—asthma	7.55e-07	3.86e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL2—asthma	7.51e-07	3.84e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—asthma	7.48e-07	3.82e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—asthma	7.47e-07	3.82e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—POMC—asthma	7.38e-07	3.77e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—asthma	7.33e-07	3.74e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—asthma	7.29e-07	3.73e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PPP2CA—asthma	7.26e-07	3.71e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—asthma	7.26e-07	3.71e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SERPINE1—asthma	7.19e-07	3.67e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—EGFR—asthma	7.18e-07	3.67e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—MMP9—asthma	7.11e-07	3.63e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PTEN—asthma	7.07e-07	3.61e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—STAT3—asthma	7e-07	3.57e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—RHOA—asthma	6.94e-07	3.54e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—EGFR—asthma	6.89e-07	3.52e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CXCL8—asthma	6.88e-07	3.52e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NOS3—asthma	6.87e-07	3.51e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—asthma	6.83e-07	3.49e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—VEGFA—asthma	6.82e-07	3.48e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—STAT3—asthma	6.75e-07	3.45e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—asthma	6.73e-07	3.44e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL2—asthma	6.58e-07	3.36e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—asthma	6.49e-07	3.31e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NOS3—asthma	6.44e-07	3.29e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—asthma	6.41e-07	3.28e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—VEGFA—asthma	6.38e-07	3.26e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—EGFR—asthma	6.36e-07	3.25e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NQO1—asthma	6.34e-07	3.24e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—asthma	6.33e-07	3.23e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—STAT3—asthma	6.32e-07	3.23e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—asthma	6.3e-07	3.22e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—asthma	6.26e-07	3.2e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—MMP9—asthma	6.22e-07	3.18e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADCY2—asthma	6.2e-07	3.17e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PTEN—asthma	6.19e-07	3.16e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—EGFR—asthma	6.14e-07	3.13e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CXCL8—asthma	6.09e-07	3.11e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—asthma	6e-07	3.06e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—asthma	5.98e-07	3.05e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTGS2—asthma	5.89e-07	3.01e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—asthma	5.86e-07	2.99e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—asthma	5.82e-07	2.97e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL2—asthma	5.82e-07	2.97e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—EGFR—asthma	5.74e-07	2.93e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—VEGFA—asthma	5.59e-07	2.85e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—POMC—asthma	5.57e-07	2.85e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—STAT3—asthma	5.53e-07	2.83e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—asthma	5.52e-07	2.82e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—MMP9—asthma	5.51e-07	2.81e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTEN—asthma	5.48e-07	2.8e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—asthma	5.29e-07	2.7e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTP1—asthma	5.29e-07	2.7e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HMOX1—asthma	5.21e-07	2.66e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ITPR1—asthma	5.2e-07	2.66e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CAT—asthma	5.14e-07	2.63e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—PTEN—asthma	5.14e-07	2.62e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—asthma	5.13e-07	2.62e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—asthma	5.08e-07	2.59e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—EGFR—asthma	5.03e-07	2.57e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—VEGFA—asthma	4.95e-07	2.53e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—STAT3—asthma	4.9e-07	2.5e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—asthma	4.89e-07	2.5e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NOS3—asthma	4.86e-07	2.48e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTM1—asthma	4.86e-07	2.48e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PLA2G4A—asthma	4.86e-07	2.48e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—asthma	4.72e-07	2.41e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—asthma	4.54e-07	2.32e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PPP2CA—asthma	4.47e-07	2.28e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—EGFR—asthma	4.45e-07	2.27e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTGS2—asthma	4.44e-07	2.27e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—asthma	4.41e-07	2.25e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—PTEN—asthma	3.88e-07	1.98e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—asthma	3.87e-07	1.97e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—POMC—asthma	3.43e-07	1.75e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—asthma	3.42e-07	1.75e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—asthma	3.13e-07	1.6e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NOS3—asthma	2.99e-07	1.53e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTGS2—asthma	2.74e-07	1.4e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PTEN—asthma	2.39e-07	1.22e-06	CbGpPWpGaD
